CYDY | CytoDyn Company profile
Company profileWe are a biotechnology company focused on developing innovative treatments for multiple therapeutic indications. Our lead candidate Leronlimab (PRO 140) belongs to a new class of therapeutics called viral-entry inhibitors and is one of the most advanced experimental monoclonal antibodies for HIV treatment.
Address1111 Main Street | NotesJump to (Finance sites)         ResearchInvestor pageir.cytodyn.comIf you are looking for News & events, Press Release, they are available on their Investors Relationssite. Their Official Profiles   Other stocks            Support this projectIf you want to help pay for server cost or for improving this tool. You can send it via Paypal. Social MediaRecommended Books Buy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949. The best book on investing ever written. |